Can surgery after chemo beat back ovarian cancer?

NCT ID NCT07171528

Recruiting now Disease control Sponsor: National Cancer Center, Korea Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether having surgery to remove remaining tumors after chemotherapy helps people with recurrent ovarian cancer live longer. About 80 participants will be randomly assigned to either have surgery or not. The goal is to see if surgery can delay the cancer from coming back or improve survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Secondary cytoreductive surgery
What this could lead to: If successful, this could show that surgery after chemotherapy helps people with recurrent ovarian cancer live longer without the disease getting worse.
What could go wrong: This is a small, early-phase trial (80 people), so results may not apply to everyone. Surgery carries risks like infection or complications, and it may not improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Carcinoma, Ovarian Epithelial fallopian tube cancer ovarian cancer ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

National Cancer Center, Korea
RECRUITING

Goyang-si, Gyeonggi-do, 10408, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.